Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Berberini Aesthetics is a South Korean medical aesthetics company specializing in the development and manufacture of hyaluronic acid (HA) dermal fillers. The company's flagship product line, Berberini, includes various formulations such as Berberini Fine, Deep, and Shape, designed for different facial augmentation and rejuvenation needs. Utilizing advanced cross-linking technology, Berberini Aesthetics focuses on providing high-purity, long-lasting, and safe injectable solutions for the global aesthetic market. The company's products are primarily used for indications such as wrinkle reduction, volume restoration, and facial contouring. Berberini Aesthetics emphasizes quality control and biocompatibility, ensuring their fillers meet international standards for safety and efficacy. The company targets both domestic and international markets, positioning itself as a provider of premium aesthetic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Berberini Aesthetics.